UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 50

Sortiert nach

Data Sharing Under the General Data Protection Regulation: Time to Harmonize Law and Research Ethics?

Hypertension (Dallas, Tex. 1979), 2021-04, Vol.77 (4), p.1029-1035

2021

Volltextzugriff (PDF)

Role of Cationic Channel TRPV2 in Promoting Prostate Cancer Migration and Progression to Androgen Resistance

Cancer research (Chicago, Ill.), 2010-02, Vol.70 (3), p.1225-1235

2010

Volltextzugriff (PDF)

Constitutively active androgen receptor variants upregulate expression of mesenchymal markers in prostate cancer cells

PloS one, 2013-05, Vol.8 (5), p.e63466-e63466

2013

Volltextzugriff (PDF)

Androgen receptor‐mediated transcriptional repression targets cell plasticity in prostate cancer

Molecular oncology, 2022-07, Vol.16 (13), p.2518-2536

2022

Volltextzugriff (PDF)

ZMIZ1 Variants Cause a Syndromic Neurodevelopmental Disorder

American journal of human genetics, 2019-02, Vol.104 (2), p.319-330

2019

Volltextzugriff (PDF)

Pleiotropic functional properties of androgen receptor mutants in prostate cancer

Human mutation, 2009-02, Vol.30 (2), p.145-157

2009

Volltextzugriff (PDF)

Cross Modulation between the Androgen Receptor Axis and Protocadherin-PC in Mediating Neuroendocrine Transdifferentiation and Therapeutic Resistance of Prostate Cancer

Neoplasia (New York, N.Y.), 2013-07, Vol.15 (7), p.761-IN22

2013

Volltextzugriff (PDF)

Osteoblasts promote castration-resistant prostate cancer by altering intratumoral steroidogenesis

Molecular and cellular endocrinology, 2016-02, Vol.422, p.182-191

2016

Volltextzugriff (PDF)

Academic carriers in oncology and radiotherapy: Update for the readers of Bulletin du Cancer

Bulletin du cancer, 2021-10, Vol.108 (10), p.895

2021

Volltextzugriff (PDF)

Implication of NPM1 phosphorylation and preclinical evaluation of the nucleoprotein antagonist N6L in prostate cancer

Oncotarget, 2016-10, Vol.7 (43), p.69397-69411

2016

Volltextzugriff (PDF)

ZMIZ1 Variants Cause a Syndromic Neurodevelopmental Disorder

American journal of human genetics, 2020-01, Vol.106 (1), p.137-137

2020

Volltextzugriff (PDF)

Dual effects of constitutively active androgen receptor and full-length androgen receptor for N-cadherin regulation in prostate cancer

Oncotarget, 2017-09, Vol.8 (42), p.72008-72020

2017

Volltextzugriff (PDF)

Risk of hormone escape in a human prostate cancer model depends on therapy modalities and can be reduced by tyrosine kinase inhibitors

PloS one, 2012-08, Vol.7 (8), p.e42252-e42252

2012

Volltextzugriff (PDF)

Identification of novel truncated androgen receptor (AR) mutants including unreported pre-mRNA splicing variants in the 22Rv1 hormone-refractory prostate cancer (PCa) cell line

Human mutation, 2010-01, Vol.31 (1), p.74-80

2010

Volltextzugriff (PDF)

A novel regulation of PSMA and PSA expression by Q640X AR in 22Rv1 and LNCaP prostate cancer cells

Cell biology international, 2013-05, Vol.37 (5), p.464-470

2013

Volltextzugriff (PDF)

Reversible Amyloid Fiber Formation in the N Terminus of Androgen Receptor

Chembiochem : a European journal of chemical biology, 2014-11, Vol.15 (16), p.2370-2373

2014

Volltextzugriff (PDF)

New Strategies for Medical Management of Castration-Resistant Prostate Cancer

Oncology, 2011-01, Vol.80 (1-2), p.1-11

2011

Volltextzugriff (PDF)

Androgen receptor variants in prostate cancer

M.S. Médecine sciences, 2017-08, Vol.33 (8-9), p.758

2017

Volltextzugriff (PDF)

Unexpected paracrine action of prostate cancer cells harboring a new class of androgen receptor mutation—A new paradigm for cooperation among prostate tumor cells

International journal of cancer, 2007-09, Vol.121 (6), p.1238-1244

2007

Volltextzugriff (PDF)

Specific properties of a C-terminal truncated androgen receptor detected in hormone refractory prostate cancer

Advances in experimental medicine and biology, 2008, Vol.617, p.529

2008

Volltextzugriff (PDF)

Hormone escape is associated with genomic instability in a human prostate cancer model

International journal of cancer, 2009-03, Vol.124 (5), p.1103-1111

2009

Volltextzugriff (PDF)

N-terminal polyglutamine-containing fragments inhibit androgen receptor transactivation function

Biological chemistry, 2008-12, Vol.389 (12), p.1455-1466

2008

Volltextzugriff (PDF)

A Splicing Variant of the Androgen Receptor Detected in a Metastatic Prostate Cancer Exhibits Exclusively Cytoplasmic Actions

Endocrinology (Philadelphia), 2007-09, Vol.148 (9), p.4334-4343

2007

Volltextzugriff (PDF)

Alternative Splicing of the Dopamine D2 Receptor Directs Specificity of Coupling to G-proteins (∗)

The Journal of biological chemistry, 1995-03, Vol.270 (13), p.7354-7358

1995

Volltextzugriff (PDF)

Constitutive activation of the androgen receptor by a point mutation in the hinge region: A new mechanism for androgen‐independent growth in prostate cancer

International journal of cancer, 2004-01, Vol.108 (1), p.152-157

2004

Volltextzugriff (PDF)

1 – 25 von 50

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(46)
Mit Volltextzugriff
(46)

Publikationsform

Artikel
(49)
Buchkapitel
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Data Sharing Under the General Data Protection Regulation: Time to Harmonize Law and Research Ethics?

Role of Cationic Channel TRPV2 in Promoting Prostate Cancer Migration and Progression to Androgen Resistance

Constitutively active androgen receptor variants upregulate expression of mesenchymal markers in prostate cancer cells

Androgen receptor‐mediated transcriptional repression targets cell plasticity in prostate cancer

ZMIZ1 Variants Cause a Syndromic Neurodevelopmental Disorder

Pleiotropic functional properties of androgen receptor mutants in prostate cancer

Cross Modulation between the Androgen Receptor Axis and Protocadherin-PC in Mediating Neuroendocrine Transdifferentiation and Therapeutic Resistance of Prostate Cancer

Osteoblasts promote castration-resistant prostate cancer by altering intratumoral steroidogenesis

Academic carriers in oncology and radiotherapy: Update for the readers of Bulletin du Cancer

Implication of NPM1 phosphorylation and preclinical evaluation of the nucleoprotein antagonist N6L in prostate cancer

ZMIZ1 Variants Cause a Syndromic Neurodevelopmental Disorder

Dual effects of constitutively active androgen receptor and full-length androgen receptor for N-cadherin regulation in prostate cancer

Risk of hormone escape in a human prostate cancer model depends on therapy modalities and can be reduced by tyrosine kinase inhibitors

Identification of novel truncated androgen receptor (AR) mutants including unreported pre-mRNA splicing variants in the 22Rv1 hormone-refractory prostate cancer (PCa) cell line

A novel regulation of PSMA and PSA expression by Q640X AR in 22Rv1 and LNCaP prostate cancer cells

Reversible Amyloid Fiber Formation in the N Terminus of Androgen Receptor

New Strategies for Medical Management of Castration-Resistant Prostate Cancer

Androgen receptor variants in prostate cancer

Unexpected paracrine action of prostate cancer cells harboring a new class of androgen receptor mutation—A new paradigm for cooperation among prostate tumor cells

Specific properties of a C-terminal truncated androgen receptor detected in hormone refractory prostate cancer

Hormone escape is associated with genomic instability in a human prostate cancer model

N-terminal polyglutamine-containing fragments inhibit androgen receptor transactivation function

A Splicing Variant of the Androgen Receptor Detected in a Metastatic Prostate Cancer Exhibits Exclusively Cytoplasmic Actions

Alternative Splicing of the Dopamine D2 Receptor Directs Specificity of Coupling to G-proteins (∗)

Constitutive activation of the androgen receptor by a point mutation in the hinge region: A new mechanism for androgen‐independent growth in prostate cancer

Suchergebnisse filtern